NOCIL Limited has reached a significant milestone in its capacity enhancement project at the Dahej facility, announcing the commencement of trial batches for rubber chemicals production. The company made this disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Project Background and Investment

The trial batch commencement follows NOCIL's earlier announcement regarding its substantial investment in capacity enhancement. The company had disclosed capital expenditure not exceeding ₹250 crore specifically allocated towards expanding rubber chemicals production capacity at its Dahej facility.

Current Development Status

The company has successfully initiated trial batches at the facility, marking a crucial phase in the project timeline. According to the official communication, the trial process involves multiple stages designed to ensure product quality and customer satisfaction.

The operational framework includes:

• Conducting comprehensive trial runs
• Sample preparation and quality assessment
• Customer sample distribution for approval
• Evaluation and feedback collection

Next Phase and Commercial Production

NOCIL has indicated that following the trial runs, samples will be sent to customers for approval processes. This customer validation phase represents a critical step before full-scale commercial operations can commence. The company has committed to providing separate intimation regarding the commencement of commercial production once the trial phase concludes successfully.

Strategic Significance

This capacity enhancement project at Dahej represents NOCIL's continued focus on expanding its rubber chemicals business. The substantial investment of up to ₹250 crore demonstrates the company's commitment to strengthening its market position and meeting growing demand in the rubber chemicals sector. The successful initiation of trial batches indicates progress toward achieving the project's operational objectives.

NOCIL Limited has addressed queries from stock exchanges regarding a significant increase in trading volume, confirming its adherence to regulatory disclosure requirements and transparency standards.

Exchange Communication Details

The company issued its clarification on March 24, 2026, in response to a letter from stock exchanges bearing reference L/SURV/ONL/PV/SG/2025-2026/998. The communication was addressed to both major Indian stock exchanges where the company's shares are listed.

Regulatory Compliance Statement

NOCIL emphasized its commitment to maintaining compliance with SEBI LODR Regulations. The company stated that it has been consistently and promptly informing stock exchanges of all events and information that have a bearing on its operations or performance.

The clarification specifically addressed concerns about potential undisclosed information by confirming that there is no undisclosed price-sensitive information or any impending announcement or corporate action requiring disclosure to exchanges at this time.

Ongoing Disclosure Commitment

The company reaffirmed its dedication to regulatory transparency by assuring stakeholders that it will continue to promptly inform exchanges of all material events, information, and actions as required under SEBI LODR Regulations 2015.

Key compliance aspects highlighted include:

• Prompt disclosure of operational developments
• Timely reporting of performance-related information
• Adherence to material event disclosure requirements
• Commitment to ongoing regulatory compliance

Corporate Authorization

The clarification was signed by Amit K. Vyas, Head-Legal and Company Secretary, who digitally signed the document on March 24, 2026, at 14:08:23 +05'30'. This formal authorization demonstrates the company's structured approach to regulatory communications and corporate governance practices.

The response concludes with a request for exchanges to take the clarification on record, indicating the company's cooperative approach to regulatory oversight and market surveillance activities.